Prostate-specific antigen-based screening
1 paper1 finding
- 1 lab in 1 country
- Funders: KWF Kankerbestrijding and 1 more
- Human trial1
Associations
1Prostate cancer-specific mortality
downin humans1RR 0.77
1 study
Prostate cancer-specific mortality
downin humans1RR 0.77
Prostate-specific antigen-based screening lowers the risk of prostate cancer-specific mortality in humans (RR 0.77, 95% CI 0.69-0.85).
Human trial20 yrmalesn = 161,380
European urology open science30 Jul 2026
Latest
1 in 12 monthsEuropean Urology Open Science
Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer
Randomised trial in 161,380 peopleProstate cancer